References PubMed Clinical trial of Selank for generalized anxiety disorder (intranasal, human study) PubMed Selank for neurasthenia: 14-day clinical trial demonstrating anxiolytic and anti-asthenic effects (human study) Hindawi BioMed Research Intranasal Selank administration review: neurobehavioral effects and clinical applications (review article) Springer Primate studies: intranasal Selank eliminates anxiety behaviors with long-term effects (preclinical) Springer Selank attenuates opioid withdrawal symptoms in animal models (preclinical dosing study) CDC Vaccine administration best practices: subcutaneous injection technique and site selection Cleveland Clinic Subcutaneous injection guide: technique, sites, and rotation principles NCBI Bookshelf Clinical procedures: injection preparation, aseptic technique, and administration standards CDC Injection safety guidelines: single-use devices, sharps disposal, and preventing unsafe practices NIBSC Peptide storage guidelines: lyophilized and reconstituted stability considerations Research Resources SS-31 (10mg/30mg/50mg Vials) Dosage Protocol Quickstart Highlights SS31 (elamipretide) is a mitochondriatargeted tetrapeptide that selectively binds cardiolipin in the inner mitochondrial membrane [1] , stabilizing electron transport chain complexes and reducing reactive oxygen species production while enhancing ATP synthesis [2]
Whether youre on one or both, take the 30-day break after 6090 days
It is not a drug, food, or cosmetic
It is proposed to work by binding actin and promoting cell migration, blood-vessel formation (angiogenesis), and collagen deposition, mechanisms studied mainly in cell cultures and animal models of wound and tendon repair
It mimics ghrelin and binds to the ghrelin receptor (GHSR) in the brain, selectively stimulating GH release from the pituitary gland, which increases plasma GH levels
(Creyghton et al., 2004.) Anti-aging benefits like increased bone mineral density
